Immunovant

Verified company

Health & Wellness

New York, United States

251-500 people

Founded 2018

Open jobs at Immunovant

5 open

5 jobs at Immunovant are for members

Members see every job, the company behind it and the direct apply link.

See member plans

From $1.46/month on the yearly plan

About Immunovant

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. 

We are a clinical-stage immunology company, dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in anti FcRn technology, we are developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.

Immunovant’s investigational product, imeroprubart (IMVT-1402), is a novel, fully human, monoclonal antibody that targets FcRn and may reduce harmful immunoglobulin G (IgG) autoantibodies, which are common causes of autoimmune disease. We believe this candidate has the potential to address a variety of IgG-mediated autoimmune diseases as a subcutaneous injection with dosing that may be tailored based on disease stage and severity.
Membership

Apply to every job, directly

  • Apply directly to every members-only job

  • AI cover letters and a resume builder, tailored to each job

  • Your own career coach and step-by-step career path

  • Full interview prep, plus career guides, ebooks and videos

  • Daily job alerts, plus company and keyword alerts you choose

See member plansFrom $1.46/month on the yearly plan

Similar companies

Shae Group
17 open jobs
Trialfacts
13 open jobs
Herbal Goodness
12 open jobs
Element Vital
6 open jobs
Partner

Need a standout CV / résumé?

Build a professional, ATS-friendly resume in minutes with CVHack — showcase your strengths and start getting interviews.

Create my resume

Copyright © Boolean Limited 2026. Terms · Privacy